Twin Securities’s SpringWorks Therapeutics SWTX Stock Holding History

Twin Securities’s Portfolio SWTX Stock Details SWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-116,100	Closed	-$5.12M	–	19
2025 Q1	$5.12M	Buy	+116,100	New	+$5.34M	2.65%	10

Other funds holding SWTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Twin Securities's SWTX Position: Q3 2025 in Review

Twin Securities sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 101,402 shares — an estimated $4.76M sold.

Twin Securities first reported a position in SWTX in Q1 2025 and held it in 2 quarters. The position peaked at $5.29M in Q1 2025. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.

Twin Securities reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
Twin Securities sold 101,402 SpringWorks Therapeutics shares in Q3 2025, an estimated $4.76M.
Twin Securities first reported a position in SpringWorks Therapeutics in Q1 2025 and held it in 2 quarters.
Twin Securities's SpringWorks Therapeutics position peaked at $5.29M in Q1 2025.
3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.

Based on Twin Securities's 13F filing for Q3 2025, filed 14 Nov 2025.